Ligand Pharma (LGND) Tops Q2 EPS by 42c
Tweet
Share
E-mailGet Alerts LGND Hot Sheet
Price: $293.95 +1.80%
Financial Fact:
Income tax expense (benefit): -160K
Today's EPS Names:
FWDI, GO, BATL, More
Financial Fact:
Income tax expense (benefit): -160K
Today's EPS Names:
FWDI, GO, BATL, More
Join SI Premium – FREE
Ligand Pharma (NASDAQ: LGND) reported Q2 EPS of $2.37, $0.42 better than the analyst estimate of $1.95. Revenue for the quarter came in at $83.7 million versus the consensus estimate of $62.93 million.
For earnings history and earnings-related data on Ligand Pharma (LGND) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Londian Wason New Energy Tech opens at $26, above IPO price of $22
- Spectrum and Optimum strike deal to restore and expand local news
- UBS Starts Nuvama Wealth Management (NUVAMA:IN) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
